In terms of natural killer cells, research by Baker et al. showed that glioma cells overexpressing galectin-1 could evade NK immune surveillance, whereas knocking down of galectin-1 culminated in tumor eradication prior to the initiation of the adaptive immune system [67]. The gene discussed is LGALS1; the disease is glioma.